What is myocardial late gadolinium enhancement (LGE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Myocardial Late Gadolinium Enhancement (LGE)?

Myocardial late gadolinium enhancement (LGE) is a cardiac MRI technique that visualizes areas of myocardial scar, fibrosis, or necrosis by detecting the differential accumulation of gadolinium-based contrast agents in damaged versus normal heart tissue, appearing as bright (hyperenhanced) regions approximately 10-15 minutes after contrast injection. 1

Technical Mechanism

LGE works through a straightforward physiological principle:

  • Gadolinium-based contrast agents distribute into the extracellular space following intravenous injection
  • In damaged myocardium (whether from infarction, inflammation, or fibrosis), there is expansion of the extracellular matrix that allows greater gadolinium accumulation
  • After 10-15 minutes, contrast washes out of normal myocardium but remains concentrated in damaged areas, creating maximum differential enhancement 1
  • Inversion-recovery pulse sequences null the signal from normal myocardium (appears black), while scarred tissue with shorter T1 values appears bright white 2, 1

Spatial Resolution and Accuracy

LGE provides near-histological precision with approximately 1×1 mm in-plane spatial resolution, allowing visualization of scar with exceptional detail 1. This technique has been extensively validated against histopathology and is now considered the reference standard for non-invasive imaging of myocardial scar and focal fibrosis in both ischemic and non-ischemic cardiomyopathies 1.

Clinical Applications

Ischemic Heart Disease

  • Predicts myocardial viability: Segments with <25% transmural LGE have high probability of functional recovery after revascularization, while >75% transmurality indicates non-viable tissue 1
  • Quantifies infarct size and transmural extent of scarring
  • The peri-infarct grey zone (mix of viable myocytes and collagen) predicts ventricular arrhythmias and appropriate ICD discharges 1

Non-Ischemic Cardiomyopathies

  • Detects myocardial necrosis and fibrosis in inflammatory conditions (myocarditis) 2
  • Characterizes hypertrophic cardiomyopathy, dilated cardiomyopathy, and infiltrative diseases
  • Helps distinguish ischemic from non-ischemic cardiomyopathy based on enhancement patterns 3

Prognostic Value

  • LGE volume and transmurality are independent predictors of mortality, with incremental value beyond ejection fraction 1
  • LGE extent >23% predicts adverse events 1
  • Predicts LV reverse remodeling after cardiac resynchronization therapy 1

Important Caveats

Limitations to Recognize:

  • LGE shows extracellular matrix expansion regardless of cause (collagen, water, amyloid infiltration), so it may overestimate scar extent in the presence of myocardial edema, particularly in acute myocardial infarction 1
  • Intermediate transmurality (25-75%) has limited predictive accuracy: sensitivity 91% but specificity only 51% for predicting regional functional recovery 1
  • Requires gadolinium-based contrast injection, which carries risks of allergic reactions/anaphylaxis and is contraindicated in pregnancy (though second/third trimester use may be safer) 1

Technical Considerations:

  • Standard protocols use phase-sensitive inversion recovery sequences with images in multiple planes (short-axis stack plus 2-, 3-, and 4-chamber long-axis views) 1
  • Interpretation should ideally be quantitative rather than purely visual 1
  • Newer high-resolution 3D whole-heart LGE techniques (up to 1.3×1.3×1.3 mm³) can detect smaller scars and atrial fibrosis, though scan times extend to ~10 minutes 4

Practical Interpretation

Normal myocardium = black (no enhancement) = viable tissue
Bright hyperenhancement = scar/fibrosis = non-viable tissue
Absence of LGE = viability 1

The transmural extent creates a spectrum: no scar (fully viable) → subendocardial scar (partially viable) → transmural scar (non-viable) 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.